Does IMATINIB Cause Peripheral arterial occlusive disease? 86 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 86 reports of Peripheral arterial occlusive disease have been filed in association with IMATINIB (Imatinib). This represents 0.2% of all adverse event reports for IMATINIB.
86
Reports of Peripheral arterial occlusive disease with IMATINIB
0.2%
of all IMATINIB reports
9
Deaths
14
Hospitalizations
How Dangerous Is Peripheral arterial occlusive disease From IMATINIB?
Of the 86 reports, 9 (10.5%) resulted in death, 14 (16.3%) required hospitalization, and 4 (4.7%) were considered life-threatening.
Is Peripheral arterial occlusive disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IMATINIB. However, 86 reports have been filed with the FAERS database.
What Other Side Effects Does IMATINIB Cause?
Death (9,708)
Drug ineffective (2,628)
Nausea (2,379)
Diarrhoea (2,203)
Fatigue (1,810)
Malignant neoplasm progression (1,716)
Vomiting (1,599)
Malaise (1,361)
Drug intolerance (1,354)
Drug resistance (1,293)
What Other Drugs Cause Peripheral arterial occlusive disease?
NILOTINIB (319)
METHOTREXATE (120)
ADALIMUMAB (116)
RIVAROXABAN (101)
PONATINIB (90)
ASPIRIN (77)
ATORVASTATIN (70)
METOPROLOL (70)
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (63)
ETELCALCETIDE (63)
Which IMATINIB Alternatives Have Lower Peripheral arterial occlusive disease Risk?
IMATINIB vs IMBRUVICA
IMATINIB vs IMDEVIMAB
IMATINIB vs IMEGLIMIN
IMATINIB vs IMETELSTAT
IMATINIB vs IMIDAPRIL